Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients

Life Sciences

Volumn 77, Issue 21, 2005, Pages 2717-2722

  Stella, Luigi ^a,b   D'ambra, Ciro ^b   Mazzeo, Filomena ^a,c   Capuano, Annalisa ^a   Del Franco, Francesco ^d   Avolio, Amalia ^a   Ambrosino, Francesco ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Servizio Tossicodipendenze ASL   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^d 2nd University of Naples ^*

Author keywords

Benzodiazepine; Naltrexone; Opioid dependence

Indexed keywords

BENZODIAZEPINE; DRONABINOL; DRUG METABOLITE; NALTREXONE; NARCORAL; OPIATE; PRAZENE; PRAZEPAM;

ABSTINENCE; ANOREXIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; HYPERALGESIA; INSOMNIA; MALE; OPIATE ADDICTION; PANIC; RELAPSE; SIDE EFFECT; SUPPORT GROUP; URINALYSIS;

ADULT; ANTI-ANXIETY AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OPIOID-RELATED DISORDERS; PRAZEPAM; RECURRENCE; SUBSTANCE ABUSE DETECTION;

EID: 24344457689     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.05.036     Document Type: Article

References (23)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV) 1994 American Psychiatric Association Washington, D.C.
2. J.W. Cornish, D. Metzger, G.E. Woody, D. Wilson, A.T. McLellan, B. Vordergrift, and C.P. O'Brein Naltrexone pharmacotherapy for opioid dependent federal probationers Journal Substance Abuse Treatment 14 6 1997 529 534
3. T.J. De Vries, and T.S. Shippenberg Neuronal system underlying opiate addiction Journal of Neuroscience 22 9 2002 3321 3325
4. R. Dingledine, L.L. Iversen, and E. Breuker Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies European Journal Pharmacology 47 1 1978 19 27
5. S. Ferracuti, G. Romeo, M.G. Leardi, and R. Lazzari New Italian adaptation and standardization of the McGill pain questionnaire Pain Supp. 5 1990 300
6. D.A. Fiellin, and P.G. O'Connor Clinical practice. Office-based treatment of opioid-dependent patients New England Journal Medicine 347 11 2002 817 823
7. G. Gekker, J.R. Lokensgard, and P.K. Peterson Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4+ lymphocyte cultures Drug Alcohol Dependence 64 3 2001 257 263
8. J.P. Gonzalez, and R.N. Brodgan Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence Drugs 35 3 1988 190 213
9. S.W. Gumulka, V. Dinnendahl, and P.S. Schonhofer The effect of naloxone on cerebellar cGMP content Naunyn-Schmiedeberg's Archives of Pharmacology 306 2 1979 169 172
10. S.R. Hathaway, and J.C. Mckinley Minnesota, Multiphasic Personality Inventory-2 (MMPI-2) 1996 Minnesota University Press
11. A.T Heikkila, O. Echenko, M. Uusi-Oukari, S.T Sinkkonen, and E.R. Korpi Morphine withdrawal increases expression of GABA (A) receptor epsilon subunit mRNA in locus coeruleus neurons Neuroreport 12 13 2001 2981 2985
12. J.H. Jaffe Drug addiction and drug abuse The Pharmacological Basis of Therapeutics 1990 Pergamon Press New York
13. U. Kirchmayer, M. Davoli, A.D. Verster, L. Amato, A. Ferri, and C.A. Perucci A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence Addiction 97 10 2002 1241 1249
14. A.T. McLellan, I.O. Arndt, D.S. Metzger, G.E Woody, and C.P. O'Brien The effect of psychosocial services in substance abuse treatment JAMA 269 15 1993 1953 1959
15. R. Melzack The McGill questionnaire: major properties and scoring methods Pain 1 1975 277 299
16. V. Modesto-Lowe, and J. Van Kirck Clinical uses of naltrexone: a review of the evidence Experimental Clinical Psychopharmacology 10 3 2002 213 227
17. F. Moroni, D.L. Cheney, E. Peralta, and E. Costa Opiate receptors agonists as modulators of gamma-aminobutyric acid turnover in the nucleus caudatus, globus pallidus and substantia nigra of the rat Journal of Pharmacology and Experimental Therapeutics 207 3 1978 870 877
18. D.E. Redmond Jr., and J.H. Krystal Multiple mechanisms of withdrawal from opioid drugs Annual Review of Neuroscience 7 1984 443 478
19. L. Stella, V. De Novellis, S. Maione, J. Leyva, M. D'amico, L. Berrino, A. Fillippelli, and F. Rossi Relationship between purinergic and glutamatergic systems in the opiate withdrawal syndrome Research Communications Molecular Pathology and Pharmacology 87 1 1995 55 56
20. L. Stella, F. Cassese, S. Barone, A. Barchetta, M. Iacobelli, G. Motola, F. Mazzeo, and F. Rossi Naltrexone to keep a drug-free condition Research Communication in Alcohol and Substances of Abuse 9 20 1999 91 98
21. M.J. Thorpy The International Classification of Sleep Disorders: Diagnostic and Coding Maual 1990 American Sleep Disorders Association Rochester, M.N.
22. A.I. Svensson, A. Bengtsson, M. Eirefelt, and B. Soderpalm Naloxone antagonizes GABA(A)/benzodiazepine receptor function in rat corticohippocampal synaptoneurosomes Journal of Neural Transmission 107 3 2000 261 270
23. J.F. Tallman, S.M. Paul, P. Skolnick, and D.W. Gallager Receptors for the age of anxiety: pharmacology of the benzodiazepines Science 207 4428 1980 274 281